What does Biogen Idec do?
What does Biogen Idec do?
Biogen Idec Inc., formed through the 2003 merger of Biogen Inc. and IDEC Pharmaceuticals Corporation (Idec), is a biotechnology company focused on developing treatments for cancer and autoimmune and inflammatory diseases.
What happened to IDEC Pharmaceuticals?
IDEC Pharmaceuticals merged with Biogen Idec for $6.4B on Jun 24, 2003 . This deal was done in Stock .
Where is Biogen Idec located?
Cambridge, Massachusetts
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen Inc. Biogen Idec Inc.
Is Biogen the same as Biogen Idec?
CAMBRIDGE, Mass. –(BUSINESS WIRE)–Effective today, Biogen Idec is known simply as Biogen (NASDAQ: BIIB).
What drugs does Biogen have?
Marketed Therapies
- ADUHELM™ (aducanumab-avwa) U.S. Full Prescribing Information.
- AVONEX® (interferon beta-1a) U.S. Full Prescribing Information.
- BENEPALI® (etanercept)
- FAMPYRA® (prolonged-release fampridine tablets)
- FLIXABI® (infliximab)
- IMRALDI™ (adalimumab)
- PLEGRIDY® (peginterferon beta-1a)
- SPINRAZA® (nusinersen)
What is Biogen famous for?
Biogen is a biotechnology company that makes only a handful of advanced drugs to treat patients with neurological diseases. More than half of Biogen’s revenues come from its drugs used to treat multiple sclerosis (MS). In mid-2021, Biogen received FDA approval for a new treatment for Alzheimer’s disease.
Is Biogen owned by Roche?
& SOUTH SAN FRANCISCO–(BUSINESS WIRE)–Biogen Idec (Nasdaq: BIIB) and Genentech, Inc. a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced that they have agreed to amend their collaboration on antibodies targeting CD20.